. The 13-subunit, 800-kilodalton eukaryotic initiation factor 3 (eIF3) organizes initiation factor and ribosome interactions required for productive translation 3 . However, current understanding of eIF3 function does not explain genetic evidence correlating eIF3 deregulation with tissue-specific cancers and developmental defects 4 . Here we report the genome-wide discovery of human transcripts that interact with eIF3 using photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) 5 . eIF3 binds to a highly specific program of messenger RNAs involved in cell growth control processes, including cell cycling, differentiation and apoptosis, via the mRNA 59 untranslated region. Surprisingly, functional analysis of the interaction between eIF3 and two mRNAs encoding the cell proliferation regulators c-JUN and BTG1 reveals that eIF3 uses different modes of RNA stem-loop binding to exert either translational activation or repression. Our findings illuminate a new role for eIF3 in governing a specialized repertoire of gene expression and suggest that binding of eIF3 to specific mRNAs could be targeted to control carcinogenesis.
Extensive genetic evidence implicates eIF3 in other functions in translation outside of its general role as a protein scaffold for the formation of initiation complexes. Mutation or inactivation of eIF3 subunits results in developmental defects in Caenorhabditis elegans and zebrafish 6, 7 . Furthermore, analyses of human tumours reveal that overexpression of eIF3 is linked to diverse cancers, including breast, prostate and oesophageal malignancies 4, 8 . The integral role of eIF3 during cellular differentiation, growth and carcinogenesis suggests that eIF3 might drive specialized translation. Consistent with this hypothesis, translation of hepatitis C virus RNA occurs through essential interactions between eIF3 and a structured internal ribosome entry site (IRES) element in the viral genome, indicating the feasibility of translation regulation being driven by distinct cellular eIF3-mRNA contacts 9 . To identify candidate transcripts regulated through direct interactions with eIF3, we first used a genome-wide approach to determine the eIF3 RNA-binding targets in human 293T cells. Because eIF3 is composed of 13 subunits (eIF3a-m), we adapted a 4-thiouridine PAR-CLIP 5 approach to allow analysis of a large multimeric complex, with isolation of individual subunit-RNA libraries (Fig. 1a) . As overexpression of single eIF3 subunits can alter complex assembly 8 , we optimized immunoprecipitation of the full endogenous eIF3 complex using an antibody that recognizes the eIF3b subunit (Fig. 1b) . High-salt washes were used to ensure removal of potentially contaminating translation factors, such as eIF4G or the small ribosomal subunit (Fig. 1c) . After RNase digestion, separation of crosslinked eIF3-RNA complexes by denaturing gel electrophoresis demonstrated that four of the thirteen subunits crosslink directly to RNA (Fig. 1d) , identified by mass spectrometry as eIF3a, b, d and g (Extended Data Fig. 1 ).
For each subunit, separate complementary DNA libraries were generated from the isolated crosslinked RNAs and deep sequenced using Illumina technology. Sequenced reads from three biological replicates were mapped to the genome and grouped into eIF3-binding sites by using the cluster-finding tool PARalyzer Tables 1 and 2 ). The limited number of interacting genes supports capture of specific eIF3-RNA contacts, as these targets compromise only ,3% of total expressed transcripts (Extended Data Fig. 2 ). As a further control, we do not see crosslinking Immunoprecipitated samples prepared from 4-thiouridine-labelled 293T cell lysates treated without ultraviolet (UV) 365 nm light are shown as a negative control. Coomassie blue staining of purified native eIF3 resolved by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) is shown for size reference.
to highly abundant ribosomal RNAs, in agreement with biochemical and structural studies showing that eIF3 interacts primarily with the proteinrich face of the small ribosomal subunit [11] [12] [13] [14] . The majority of RNAs contained a single eIF3-binding site, with a median cluster length of 25 nucleotides (Fig. 2a, b) . These RNAs interact with distinct combinations of eIF3a, b, d and g subunits (Fig. 2c) . To validate the RNAs identified by PAR-CLIP, we performed eIF3 immunoprecipitation in the absence of crosslinking. We detected eIF3-RNA interactions for five top candidate genes using polymerase chain reaction with reverse transcription (RT-PCR); whereas a negative control mRNA, the PSMB6 transcript, was not immunoprecipitated (Fig. 2d) .
In eukaryotic protein synthesis, the 59 UTR of mRNA is thought to be the major site of translation regulation 3 . In agreement with identifying translation regulation roles of specific eIF3-mRNA interactions, the eIF3-binding sites predominantly mapped to the 59 UTR (,70%) (Fig. 2e) . To examine the impact of transcript-specific engagement of eIF3 on translational control, we focused on two genes with an eIF3-binding site in the 59 UTR, c-JUN and B-cell translocation gene 1 (BTG1) (Fig. 3a,  b) . c-JUN is a member of the immediate early response transcription factor AP1 and a positive mitotic regulator 15 . In contrast, BTG1 acts as a negative regulator of proliferation and its expression induces cellular differentiation 16, 17 . Because of the opposing effects of c-JUN and BTG1 on cellular growth, we wanted to understand why eIF3 would interact with both mRNAs. We constructed luciferase reporters containing the 59 UTR of c-JUN or BTG1 with or without the eIF3 crosslinking site identified by PAR-CLIP (Fig. 3c) . Deletion of the crosslinking site from the 59 UTR of c-JUN abolished translation of mRNAs transfected into cells, indicating that eIF3 binding is required for efficient translation (Fig. 3d) . In stark contrast, BTG1 translation was highly upregulated when the eIF3-binding site was removed from the mRNA (Fig. 3e) . Furthermore, treatment of 293T cell in vitro translation extracts with m 7 G cap analogue inhibited translation of both c-JUN and BTG1 luciferase reporter mRNAs, demonstrating that eIF3-dependent translation regulation of these transcripts is cap-dependent and thus distinct from viral IRES-like mechanisms 18 (Fig. 3f, g ). These results demonstrate that eIF3 can act as both a translation activator and repressor of specific cellular mRNAs.
To understand how eIF3 binding to mRNA leads to opposing translation phenotypes, we next identified the full RNA elements for eIF3 recognition in the c-JUN and BTG1 mRNAs. While PAR-CLIP marks the localized vicinity of eIF3 in the 59 UTR, eIF3 interaction could occur either through recognition of a linear sequence or in the context of RNA secondary structure. Using selective 29-hydroxyl acylation analysed by primer extension (SHAPE), we experimentally determined the secondary structure around the eIF3-binding sites (Fig. 4a, d ). For both c-JUN and BTG1, SHAPE revealed that the eIF3-binding sites map to structured 
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G2015 Macmillan Publishers Limited. All rights reserved RNA regions corresponding to conserved stem-loops (Extended Data Fig. 3 ). For the c-JUN mRNA element, we investigated the importance of secondary structure in eIF3 recognition by mutating base-pairing interactions of five nucleotides in the stem while leaving the crosslinking site intact (Fig. 4b ). eIF3 directly bound to the c-JUN stemloop, but not the mutated stem-loop, as determined by native agarose gel electrophoresis with radiolabelled RNA and recombinant or native eIF3 ( Fig. 4b and Extended Data Fig. 4) . Furthermore, the same mutations in the c-JUN luciferase reporter mRNA led to the identical translation phenotype as deletion of the full eIF3 crosslinking site ( Fig. 4c and Extended Data Fig. 5a ). Unlike its interactions with the c-JUN RNA, eIF3 was unable to bind to the BTG1 stem-loop in a binary fashion (Extended Data Fig. 4b ). As eIF3 immunoprecipitates BTG1 mRNA in cell lysates (Fig. 2d ), this suggests that other currently unknown factors are required for this mode of eIF3-RNA interaction. To verify that the BTG1 stem-loop is sufficient for the inhibitory translation phenotype of eIF3 binding, we asked whether addition of the stem-loop could block translation driven by the PSMB6 59 UTR, which does not interact with eIF3 ( Fig. 2d) . Transplantation of the BTG1 stem-loop into the PSMB6 59 UTR conferred translation inhibition ( Fig. 4e and Extended Data Fig. 5b) . Importantly, addition of the transversed BTG1 stem-loop sequence does not alter PSMB6 translation, confirming that BTG1 stem-loop-driven translation repression is eIF3-specific and not due to introduction of a potentially deleterious RNA secondary structure 19 ( Fig. 4e and Extended Data Fig. 5b ). Together, these results demonstrate that during translation activation, eIF3 recognizes the c-JUN mRNA by directly binding to a sequence in the context of a stem-loop structure; whereas during translation inhibition, eIF3 binding to the BTG1 stem-loop requires the presence of additional factors or modifications.
Although misregulation of eIF3 levels is implicated in carcinogenesis, it was previously unknown if eIF3 activities lead to these cell growth alterations 4, 8 . Gene ontology analysis of the PAR-CLIP results establish direct binding of eIF3 to RNA targets enriched in cancer-associated cell growth regulation pathways, such as apoptosis, cell cycling and differentiation (Extended Data Fig. 6a ). The combination of these targets may represent a gene program that supports overactive cell proliferation during eIF3-related malignancies. In support of this, our results demonstrate that eIF3 acts as a positive translational regulator of c-JUN, which is a proto-oncogene required for RAS-mediated transformation 20 ; anda negative regulator of BTG1, of which genomic deletions are found in 9% of B-cell precursor acute lymphoblastic leukaemias 21 . Furthermore, circumventing eIF3 translational control by knockdown of c-JUN or overexpression of BTG1 decreases cell invasiveness of H1299 human lung cancer cells, which overexpress eIF3a 22 (Fig. 4f, g and Extended Data Fig. 6 ). Thus, we suggest that the RNAs identified by PAR-CLIP may be co-opted 
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G2015 Macmillan Publishers Limited. All rights reserved upon eIF3 overexpression, leading to loss of correct translational control of cell growth and eventual malignancy. Although it is surprising that eIF3 can act as both a repressor and activator of translation, analogous contrasting functions have been found with other multi-protein complexes. For example, the RNA polymerase II regulation complex Mediator consists of at least 30 proteins in humans. It directs either transcription activation or repression, dependent on promoter sequence, gene-specific regulatory proteins, and altered phosphorylation states of subunits 23 . Intriguingly, more than 25 posttranslational modifications have been detected on eIF3, with a number of them at substoichiometric levels 24, 25 , and eIF3 association with other translation regulatory proteins such as the helicase eIF4B is regulated by mitogenic signalling 26 . Furthermore, modelling of the eIF3 subunits, except for eIF3d, reveals that the crosslinked subunits form a nexus in a distal region of eIF3 positioned near the mRNA entry tunnel (Extended Data Fig. 7) 
14
. As the PAR-CLIP sites exhibit all variations of interactions with the four eIF3 subunits (Fig. 2c) , we propose that there may be multiple modes of eIF3-RNA interactions driven by this region of eIF3 (refs 12, 13) .
Recent studies have highlighted that certain factors possess roles outside of their general functions in translation. For example, the ribosome mediates translational specificity during development and viral infection through the requirement for distinct ribosomal proteins 27, 28 . During canonical translation, eIF3 acts as a protein scaffold for initiation complex assembly 3 . Our results now reveal a new paradigm for translational control, in which, in addition to this general function, eIF3 can act as both an activator and repressor of cap-dependent transcript-specific translation through direct binding to defined RNA structural elements.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.
METHODS
Cells and transfections. Human 293T cells were maintained in DMEM (Invitrogen) with 10% FBS (Tissue Culture Biologicals). H1299 cells were maintained in RPMI-1640 ATCC-formulated (ATCC) with 10% FBS. IMR90 cells were maintained in Eagles MEM (ATCC) with 10% FBS. RNA transfections were performed using TransIT mRNA reagent (Mirius), with the following modifications to the manufacturer's protocol. Twenty-four hours before transfection, 293T cells were seeded into opaque 96-well plates to be at ,80% confluence at the time of transfection. For each well, 9 ml of pre-warmed OptiMEM (Invitrogen) was mixed with 90 ng of RNA, 0.27 ml of Boost reagent and 0.27 ml of TransIT mRNA reagent. Reactions were incubated for 3 min at room temperature, added drop-wise to the well, and luciferase activity was assayed 18 h after transfection. Plasmid transfections were performed using Lipofectamine 2000 (Invitrogen), according to the manufacturer's protocol, and Matrigel or western blot assays were performed 48 h after transfection. siRNA transfection was performed using Lipofectamine 2000, with the following modifications to the manufacturer's protocol. Forty-eight hours after transfection, cells were split into new 6-well plates to be at ,70% confluence 24 h after seeding. These cells were then transfected for a second time with siRNA, and harvested for Matrigel or western blot assays 48 h after the second transfection. Plasmids and siRNAs. To generate the c-JUN and BTG1 59 UTR luciferase reporter plasmids, sections of the 59 UTR were first amplified from human cDNA. These were then stitched together downstream of a T7 promoter using overlap-extension PCR and Gibson cloning. For the PSMB6 59 UTR luciferase reporter plasmid, the 59 UTR was constructed by annealing primers together to create restriction-site-compatible overhangs. The 59 UTRs were then inserted together with Renilla luciferase into pUC19 for c-JUN and pcDNA4 for BTG1 and PSMB6. The eIF3-binding mutants and BTG1 stem-loop chimaeras were made by inserting annealed primers after cutting the plasmid with enzymes flanking the desired insertion site. The BTG1 overexpression plasmid was constructed by inserting the BTG1 open reading frame, isolated by PCR from human cDNA, into pcDNA4 modified with a Kozak sequence 30 . siRNA pools used were siGENOME JUN (Dharmacon M-003268-03) and siGENOME Non-Targeting siRNA #3 (Dharmacon D-001210-03). Western blot. Western blot analysis was performed using the following antibodies: anti-eIF3a (Novus NBP1-18891); anti-eIF3b (Bethyl A301-761A); anti-eIF3c (Bethyl A300-376A); anti-eIF3d (Bethyl A301-758A); anti-eIF3e (Bethyl A302-985A); antieIF3f (Bethyl A303-005A); anti-eIF3g antibody (Bethyl A301-757A); anti-eIF3h antibody (Bethyl A301-754A); anti-eIF3i (Biolegend 646701); anti-eIF3k (Novus NB100-93304); anti-eIF3l antibody (Genetex GTX120119); anti-eIF3m (Novus NBP1-56654); anti-rpS19 (Bethyl A304-002A); anti-eIF4G1 (Bethyl A301-775A); anti-c-JUN (Bethyl A302-959A); anti-BTG1 (Abcam ab151740). anti-GAPDH (Bethyl A300-640A); and anti-HSP90 (BD 610418). In vitro transcription. RNAs were made by in vitro transcription with T7 RNA polymerase (NEB). For luciferase RNAs, transcription was performed in the presence of 39-O-Me-m 7 G(59)ppp(59)G RNA Cap Structure Analogue (NEB), using linearized plasmid as the template, and polyadenylated using polyA polymerase (Invitrogen). For gel shifts, annealed oligonucleotides were used as the template, and RNAs were radiolabelled by capping with vaccinia virus enzymes (NEB) and [a-32 P]-GTP. For SHAPE reactions, PCR templates were made using primers to add a 39 handle (59-GAACCGGACCGAAGCCCGGGCTGAG-39), and transcription was performed using gel-extracted PCR products. RNAs were purified by phenol-chloroform extraction and ethanol precipitation or using the RNA Clean and Concentrator Kit (Zymo). In vitro translation. In vitro translation extracts were made from 293T cells using a previously described protocol 31 . Briefly, cells were trypsinized and collected by centrifugation for 5 min at 1,000g at 4 uC. Cells were washed once with cold PBS (137 mM NaCl, 2.7 mM KCl, 100 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 ) and an equal volume of freshly made cold lysis buffer (10 mM HEPES-KOH pH 7.6, 10 mM KOAc, 0.5 mM Mg(OAc) 2 , 5 mM dithiothreitol (DTT), and 1 Complete EDTAfree Proteinase Inhibitor Cocktail tablet (Roche) per 10 ml of buffer) was added. After hypotonic-induced swelling for 45 min on ice, cells were homogenized using a syringe attached to a 27G needle until ,95% of cells burst, as monitored by trypan blue staining. Lysate was centrifuged at 14,000g for 1 min at 4 uC, and supernatant was moved to a new tube, avoiding the top lipid layer. Lysates were quickly frozen with liquid nitrogen and stored at 280 uC. Each translation reaction contained 50% in vitro translation lysate and buffer to make the final reaction with 0.84 mM ATP, 0.21 mM GTP, 21 mM creatine phosphate (Roche), 45 U ml 21 creatine phosphokinase (Roche), 10 mM HEPES-KOH pH 7.6, 2 mM DTT, 2 mM Mg(OAc) 2 , 50 mM KOAc, 8 mM amino acids (Promega), 255 mM spermidine and 1 U ml 21 murine RNase inhibitor (NEB). One millimolar m 7 G(59)ppp(59)G RNA cap structure analogue (NEB) was added to reactions when indicated. Translation reactions were incubated for 1 h at 30 uC, after which luciferase activity was assayed. eIF3 purification and native agarose gel electrophoresis. Recombinant eIF3 was expressed and purified from Escherichia coli and native human eIF3 was purified from HeLa cells as previously described 32 . The gel shift protocol was adapted from previously described protocols 33, 34 . A 0.7% agarose gel was prepared using Agarose Type 1B (Sigma A0576) in buffer consisting of 13 TBE supplemented with 75 mM KCl, and gel and buffer were pre-cooled at 4 uC. For each gel shift, 2 ml water, 1 ml of 53 Binding Buffer (125 mM Tris-HCl pH 7.5, 25 mM Mg(OAc) 2 , 350 mM KCl, 0.5 mM CaCl 2 , 0.5 mg ml 21 BSA, 10 mM TCEP), 1 ml labelled RNA and 1 ml of purified eIF3 or protein buffer were added, in the listed order, and incubated at 25 uC for 30 min. One microlitre of room temperature 63 non-denaturing loading dye (40% w/v sucrose, with xylene cyanol and bromophenol blue) was added to the reactions and these were loaded on the agarose gel. The gel was run for 1 h at 40 V at 4 uC, buffer was replaced with fresh cold buffer, and the gel was run for another hour at 40 V. The gel was placed on top of positively charged nylon membrane with four pieces of Whatman filter paper underneath, covered in saran wrap, and dried for 1 h at 75 uC on a pre-heated gel drier. The gel was imaged using a phosphoimager. SHAPE mapping of RNA structure. The SHAPE protocol was adapted from a previously described protocol 35 . Each RNA folding reaction contained 1 mg of RNA, 1.8 ml 53 annealing buffer (500 mM HEPES-KOH pH 8.0, 250 mM KCl, 12.5 mM MgCl 2 ), and water to make the total reaction volume 9 ml. RNAs were incubated at 65 uC for 5 min, ice for 5 min, and then at 25 uC for 5 min. To each tube, 1 ml of 100% dimethylsulfoxide (DMSO) or 1 ml of 800 mM benzoyl cyanide (Sigma) was added, and the reaction was mixed by pipetting three times. The RNAs were immediately recovered by ethanol precipitation. Purified RNA was dissolved in 9 ml of 0.53 TE buffer (5 mM Tris, 0.5 mM EDTA pH 8.0). Three microlitres of 0.3 mM NED-or VIC-labelled primers were added to the modified and unmodified reactions, respectively. For sequencing reactions, 1 mg of RNA in 1 ml volume was mixed with 8 ml of 0.53 TE buffer, and 3 ml of 0.3 mM FAM-or PET-labelled primers were added to each tube with 1 ml of 10 mM ddATP or ddTTP. To each tube, 7 ml of reverse transcription buffer (250 mM KCl, 167 mM Tris-HCl pH 8.3, 1.67 mM dNTPs, 17 mM DTT and 10 mM MgCl 2 ) was added and the reactions were prewarmed to 52 uC for 1 min. One microlitre of Superscript III (Invitrogen) was added and the tubes were incubated at 52 uC for 50 min, 65 uC for 5 min, and then put on ice. The RNA was hydrolysed by adding 0.5 ml 10 N NaOH, heating to 95 uC for 3 min, put on ice, and then neutralized by adding 0.33 ml of 12.1 M HCl. cDNAs were recovered by ethanol precipitation and resuspended in 11 ml of deionized formamide. Fragment analysis was performed using an Applied Biosystems 3730XL DNA Analyzer, and raw traces were analysed using Shapefinder software 36 . Matrigel invasion assay. Matrigel assays were performed using Corning BioCoat Matrigel invasion chambers according to the manufacturer's protocol. Twenty-four hours after seeding the invasion chambers, invaded cells were fixed with 70% ethanol and stained with crystal violet before imaging. PAR-CLIP. Three biological replicates of PAR-CLIP were performed as previously described 5 , with some modifications. For each experiment, 40-50 150 mm plates of 293T cells were seeded to be at ,90% confluence during crosslinking. Fourteen hours before crosslinking, 4-thiouridine (Sigma) was added to the media to a final concentration of 100 mM. For crosslinking, the cells were washed with cold PBS and then the plates were irradiated on ice with 0.15 J cm 22 of UV 365 nm light. The cells were scraped into PBS, pelleted by centrifugation at 1,000g for 5 min at 4 uC, and the pellet was resuspended in three volumes of NP40 lysis buffer (50 mM HEPES-KOH pH 7.5, 150 mM KCl, 2 mM EDTA, 0.5% Nonidet P-40 alternative, 0.5 mM DTT, 1 Complete EDTA-free Proteinase Inhibitor Cocktail tablet per 50 ml of buffer). The cell suspension was incubated on ice for 10 min, passed through an 18G needle five times, and centrifuged at 13,000g for 15 min at 4 uC. The lysate was filtered through a 0.2 mm membrane syringe filter and RNAs were lightly digested by treatment with RNase T1 (Thermo Scientific) at a final concentration of 0.05 U ml 21 for 15 min at room temperature. For each plate, 5 ml of Dynabeads (Invitrogen) and 10 ml of antieIF3b antibody (Bethyl A301-761A) were prepared by washing the beads once with PBS and 0.2% Tween-20, and then allowing the antibody to bind to the beads in PBS and 0.2% Tween-20 by rotating at room temperature for 15 min. The antibody and beads were added to the lysates and the immunoprecipitation was rotated at 4 uC for 2 h.
The beads were collected and washed three times in high-salt NP40 wash buffer (50 mM HEPES-KOH pH 7.5, 500 mM KCl, 0.5% Nonidet P-40 alternative, 0.5 mM DTT, 1 Complete EDTA-free Proteinase Inhibitor Cocktail tablet per 50 ml of buffer). One bead volume of NP40 lysis buffer and 50 U ml 21 RNase T1 was added to the beads and incubated for 16 min at room temperature. Beads were washed three times in high-salt NP40 wash buffer and resuspended in one bead volume of Buffer 3 (NEB) with 0.5 U ml 21 Calf Intestinal Phosphatase (NEB). The reaction was incubated at 37 uC for 10 min, and beads were washed twice in phosphatase wash buffer (50 mM Tris-HCl pH 7.5, 20 mM EGTA, 0.5% v/v Nonidet P-40 alternative) and twice in PNK buffer without DTT (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 10 mM MgCl 2 ). Beads were resuspended in one bead volume of PNK buffer with 0.5 mCi ml 21 [ - 32 P]-ATP and 1 U ml 21 T4 PNK (NEB), and incubated for 20 min at 37 uC. Onehundred micromolar nonradioactive ATP was added and the reaction was incu-LETTER RESEARCH bated for 5 min at 37 uC, and then beads were washed five times with PNK buffer without DTT. SDS-PAGE loading dye (50 mM Tris-HCl pH 6.8, 100 mM b-mercaptoethanol, 2% w/v SDS, 10% v/v glycerol, 0.1% bromophenol blue) was added to the beads, the sample was boiled for 5 min, and the sample was loaded onto a BisTris 4-12% Bis-Tris gel (Novex) and electrophoresed in MOPS buffer (2.5 mM MOPS, 2.5 mM Tris base, 0.005% w/v SDS, 1 mM EDTA). As a size standard, native eIF3 was loaded onto the same gel.
The gel was imaged using a phosphoimager, a printed image was aligned to the gel, and the complexes were excised and electroeluted in a D Tube Dialyzer Midi (Millipore) for 2.5 h at 150 V, at 4 uC. The protein was digested with 1.2 mg ml 21 Proteinase K (Roche) in Proteinase K buffer (50 mM Tris-HCl pH 7.5, 75 mM NaCl, 6.25 mM EDTA, 1% w/v SDS) for 30 min at 37 uC. The RNA was isolated by phenol-chloroform extraction and ethanol precipitation, and small RNA libraries were prepared using a standard protocol 37 . The cDNA libraries were sequenced on an Illumina HiSeq 2000. Mass spectrometry. Protein samples were prepared alongside the sequencing samples used for RNA library preparation, using five plates and substituting nonradioactive ATP during the T4 PNK labelling step. The samples were run on the same gel as the radiolabelled PAR-CLIP samples and cut out using the phosphorimager printout as a guide. Mass spectrometry samples were prepared by in-gel tryptic digestion 38 and peptides were identified by liquid chromatography-mass spectrometry (LC-MS). Denaturing immunoprecipitation. The denaturing immunoprecipitation was performed using the PAR-CLIP protocol, with the following alterations. Five plates were used for each sample and, after crosslinking, one volume of NP40 lysis buffer was added and the sample was incubated on ice for 10 min. The lysate was clarified by centrifugation, the supernatant was transferred to a new tube, and one volume of 23 SDS lysis buffer (10% w/v SDS, 100 mM Tris-HCl pH 7.4, 10 mM EDTA, 20 mM DTT) was added. The sample was boiled for 5 min, cooled on ice, and then diluted at least tenfold with nondenaturing lysis buffer (1% v/v Triton-X-100, 50 mM HEPES-KOH pH 7.5, 150 mM NaCl, 2 mM EDTA). Immunoprecipitation was performed using an anti-eIF3d (Bethyl A301-758A) or anti-eIF3g (Bethyl A301-757A) antibody. PAR-CLIP computational analysis. Raw Illumina reads were collapsed using fastx_collapser from FASTX Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/), and 39 adapters were removed using Cutadapt (http://code.google.com/p/cutadapt/). Reads shorter than 15 nucleotides were discarded. To remove processed reads that align to repeat elements, reads were mapped using Bowtie 39 to the hg19 RepeatMasker track from the UCSC table browser, and unmapped reads were retained. Retained reads were mapped to the hg19 reference genome, allowing for up to two mismatches in alignment. PARalyzer 10 was used to identify read clusters, or eIF3 crosslinking sites, with settings of five minimum read counts per group, cluster or kernel density estimation (KDE), a minimum cluster size of 11 nucleotides, and a minimum conversion count of 1. Clusters were annotated using iterative rounds of bedtools intersect 40 , with the following hierarchy: start codon, stop codon, 59 UTR, 39 UTR, CDS, intron, lincRNA, miRNA, piwiRNA, snoRNA, snRNA, mitoRNA, rRNA, pseudogene, miscRNA. Annotation data were from the following sources: Gencode (v17 annotation) (http:// www.gencodegenes.org), Ensembl BioMart, ncRNA database (http://www.ncrna.org/), miRBase (http://www.mirbase.org). Clusters that aligned to intergenic regions or that were antisense to the transcript were removed, along with any clusters that mapped identically but in the correct sense, as these are probably due to incorrect mapping 41 . Next, the consensus set of clusters was defined as a cluster that was reproduced in at least two of the three biological replicates 41 Extended Data Figure 7 | Schematic of eIF3 subunit localization on the small ribosomal subunit. The eIF3 subunits bound to RNA in the PAR-CLIP experiment, eIF3a, b and g, form a nexus in the distal eIF3 region. The location of eIF3d has not been assigned, and the schematic is adapted from ref. 14.
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